14,240,044 vaccines have already arrived in Colombia, cut-off as of June 2, 2021, according to details the document of the Administrative Department of the Presidency of the Republic (Dapre).
The vaccine that has reached the country in greater quantities is the Chinese vaccine of Sinovac, which has already received the approval of the WHO, and has in Colombia 7,500,004 doses to be inoculated.
Later, there is the vaccine from the American pharmaceutical company Pfizer. Of this biological they have already arrived in the country 5,583,240 doses to be administered.
The third vaccine that has reached Colombia is the one produced by the British-Swedish pharmaceutical company AstraZeneca. Of this they have been delivered 1,156,800 doses to the country for application.
Similarly, Dapre indicated in its most recent report that in the coming days more vaccines will be arriving in the country in the following order:
- June 2, Pfizer, 583,200 doses.
- June 3, AstraZeneca, 909,000 doses.
- June 3, Pfizer, 539,370 doses.
- June 6, Sinovac, 1,000,000 doses.
- June 9, Pfizer, 538,200 doses.
- June 10, Pfizer, 539,370 doses.
What is the best vaccine against COVID-19?
Yes OK all vaccines approved in phase 3 (Pfizer, Moderna, Sputnik V, Sinopharm, AstraZeneca, Janssen y Sinovac) reduce the risk of severe disease and mortality by almost 100% for COVID-19, according to WHOSome are more effective than others in preventing mild symptoms.
Pfizer (95%), Moderna (94%) and Sputnik V (91%) are the approved phase 3 vaccines that are most effective in preventing mild COVID-19 symptoms. Of these, Pfizer and Moderna (from July) will be applied in Colombia.
These are government recommendations for the application of vaccines:
Where does Pfizer’s COVID-19 vaccine come from?
Developed by the American pharmaceutical company Pfizer and German firm BioNTech, this was the first COVID-19 vaccine available in the United States and approved globally (December 2020).
“Pfizer’s COVID-19 vaccine is based on messenger RNA (mRNA) technology. MRNA vaccines contain a code that provides “instructions” to cells in order to create antibodies to protect against COVID-19, “details the University of Maryland laboratory about this biological.
Where is the AstraZeneca COVID-19 vaccine from?
This vaccine was developed by the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca.
It is a vector vaccine that carries within a harmless virus other than the coronavirus the genetic information necessary for the human body to “produce antibodies / immune response against the S protein of SARS-CoV-2,” The Lancet medical journal details.
Unlike Pfizer’s vaccine, which uses a new technology (mRNA), this type of vaccine has already been used previously in biologicals that fight viruses such as Ebola or Zika.
This is a report from the WHO and AstraZeneca vaccines:
Where is Sinovac’s COVID-19 vaccine from?
This vaccine, recently approved by WHO for the Covax system, is produced by the Beijing Bio-Institute of Biological Products, a subsidiary of the government company China National Biotech Group (CNBG).
The biological consists of an “inactivated virus that tells the immune system how to generate antibodies against COVID-19.” For its development, the scientists cultivated the virus in kidney cells and, through the use of some chemicals, inactivated it to prevent its spread and generate a response in the immune system. study published by The Lancet.